Impaired CK1 delta activity attenuates SV40-induced cellular transformation in vitro and mouse mammary carcinogenesis in Vivo

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Hirner, Heidrun ^a   Günes, Cagatay ^a   Bischof, Joachim ^a   Wolff, Sonja ^a   Grothey, Arnhild ^a   Kühl, Marion ^b   Oswald, Franz ^a   Wegwitz, Florian ^b   Bösl, Michael R ^c   Trauzold, Anna ^d   Henne Bruns, Doris ^a   Peifer, Christian ^e   Leithäuser, Frank ^a   Deppert, Wolfgang ^b   Knippschild, Uwe ^a  

^a UNIVERSITY OF ULM   (Germany)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^c MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PROTEIN; CASEIN KINASE IDELTA; UNCLASSIFIED DRUG; VIRUS T ANTIGEN; WHEY ACIDIC PROTEIN; WNT PROTEIN; MILK PROTEIN; WHEY ACIDIC PROTEINS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; CANCER INCIDENCE; CELL TRANSFORMATION; CONTROLLED STUDY; DNA REPAIR; ENZYME ACTIVITY; GENE MUTATION; IN VITRO STUDY; IN VIVO STUDY; LIFESPAN; MALE; MOLECULAR MODEL; MOUSE; NONHUMAN; ONCOGENE; PHENOTYPE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; SIMIAN VIRUS 40; TUMOR GROWTH; WAP GENE; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; DISEASE COURSE; ENZYMOLOGY; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MUTATION; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; SURVIVAL; TRANSGENIC MOUSE; TUMOR CELL LINE; UDDER; VIROLOGY; VIRUS CELL TRANSFORMATION;

ANIMALIA; MUS; MUS MUSCULUS; SIMIAN VIRUS 40;

ANIMALS; ANTIGENS, VIRAL, TUMOR; CASEIN KINASE IDELTA; CELL LINE; CELL LINE, TUMOR; CELL TRANSFORMATION, VIRAL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION; MALE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MILK PROTEINS; MODELS, MOLECULAR; MUTATION; PHENOTYPE; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, TERTIARY; SIMIAN VIRUS 40; SURVIVAL ANALYSIS;

EID: 84855304112     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029709     Document Type: Article

References (82)

1. Glineur C, Zenke M, Beug H, Ghysdael J, (1990) Phosphorylation of the v-erbA protein is required for its function as an oncogene. Genes Dev 4: 1663-1676.
2. Luscher B, Christenson E, Litchfield DW, Krebs EG, Eisenman RN, (1990) Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation. Nature 344: 517-522.
3. Alsheich-Bartok O, Haupt S, Alkalay-Snir I, Saito S, Appella E, et al. (2008) PML enhances the regulation of p53 by CK1 in response to DNA damage. Oncogene 27: 3653-3661.
4. Chen L, Li C, Pan Y, Chen J, (2005) Regulation of p53-MDMX interaction by casein kinase 1 alpha. Mol Cell Biol 25: 6509-6520.
5. Honaker Y, Piwnica-Worms H, (2010) Casein kinase 1 functions as both penultimate and ultimate kinase in regulating Cdc25A destruction. Oncogene 29: 3324-3334.
6. Huart AS, MacLaine NJ, Meek DW, Hupp TR, (2009) CK1alpha plays a central role in mediating MDM2 control of p53 and E2F-1 protein stability. J Biol Chem 284: 32384-32394.
7. Inuzuka H, Tseng A, Gao D, Zhai B, Zhang Q, et al. (2010) Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligase. Cancer Cell 18: 147-159.
8. Knippschild U, Milne DM, Campbell LE, DeMaggio AJ, Christenson E, et al. (1997) p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs. Oncogene 15: 1727-1736.
9. Sakanaka C, (2002) Phosphorylation and regulation of beta-catenin by casein kinase I epsilon. J Biochem 132: 697-703.
10. Winter M, Milne D, Dias S, Kulikov R, Knippschild U, et al. (2004) Protein kinase CK1delta phosphorylates key sites in the acidic domain of murine double-minute clone 2 protein (MDM2) that regulate p53 turnover. Biochemistry 43: 16356-16364.
11. Deppert W, Kurth M, Graessmann M, Graessmann A, Knippschild U, (1991) Altered phosphorylation at specific sites confers a mutant phenotype to SV40 wild-type large T antigen in a flat revertant of SV40-transformed cells. Oncogene 6: 1931-1938.
12. Cegielska A, Moarefi I, Fanning E, Virshup DM, (1994) T-antigen kinase inhibits simian virus 40 DNA replication by phosphorylation of intact T antigen on serines 120 and 123. J Virol 68: 269-275.
13. Grasser FA, Scheidtmann KH, Tuazon PT, Traugh JA, Walter G, (1988) In vitro phosphorylation of SV40 large T antigen. Virology 165: 13-22.
14. Umphress JL, Tuazon PT, Chen CJ, Traugh JA, (1992) Determinants on simian virus 40 large T antigen are important for recognition and phosphorylation by casein kinase I. Eur J Biochem 203: 239-243.
15. Knippschild U, Wolff S, Giamas G, Brockschmidt C, Wittau M, et al. (2005) The role of the casein kinase 1 (CK1) family in different signaling pathways linked to cancer development. Onkologie 28: 508-514.
16. Brockschmidt C, Hirner H, Huber N, Eismann T, Hillenbrand A, et al. (2008) Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo. Gut 57: 799-806.
17. Frierson HF Jr, El-Naggar AK, Welsh JB, Sapinoso LM, Su AI, et al. (2002) Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol 161: 1315-1323.
18. Husler MR, Kotopoulis KA, Sundberg JP, Tennent BJ, Kunig SV, et al. (1998) Lactation-induced WAP-SV40 Tag transgene expression in C57BL/6J mice leads to mammary carcinoma. Transgenic Res 7: 253-263.
19. Saenz Robles MT, Pipas JM, (2009) T antigen transgenic mouse models. Semin Cancer Biol 19: 229-235.
20. Schulze-Garg C, Lohler J, Gocht A, Deppert W, (2000) A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland. Oncogene 19: 1028-1037.
21. Tzeng YJ, Guhl E, Graessmann M, Graessmann A, (1993) Breast cancer formation in transgenic animals induced by the whey acidic protein SV40 T antigen (WAP-SV-T) hybrid gene. Oncogene 8: 1965-1971.
22. Bauer M, Guhl E, Graessmann M, Graessmann A, (1987) Cellular mutation mediates T-antigen-positive revertant cells resistant to simian virus 40 transformation but not to retransformation by polyomavirus and adenovirus type 2. J Virol 61: 1821-1827.
23. Graessmann M, Graessmann A, (1983) Microinjection of tissue culture cells. Methods Enzymol 101: 482-492.
24. Knippschild U, Kiefer J, Patschinsky T, Deppert W, (1991) Phenotype-specific phosphorylation of simian virus 40 tsA mutant large T antigens in tsA N-type and A-type transformants. J Virol 65: 4414-4423.
25. Scheidtmann KH, Haber A, (1990) Simian virus 40 large T antigen induces or activates a protein kinase which phosphorylates the transformation-associated protein p53. J Virol 64: 672-679.
26. Burdon T, Sankaran L, Wall RJ, Spencer M, Hennighausen L, (1991) Expression of a whey acidic protein transgene during mammary development. Evidence for different mechanisms of regulation during pregnancy and lactation. J Biol Chem 266: 6909-6914.
27. Pittius CW, Hennighausen L, Lee E, Westphal H, Nicols E, et al. (1988) A milk protein gene promoter directs the expression of human tissue plasminogen activator cDNA to the mammary gland in transgenic mice. Proc Natl Acad Sci U S A 85: 5874-5878.
28. Zerrahn J, Knippschild U, Winkler T, Deppert W, (1993) Independent expression of the transforming amino-terminal domain of SV40 large I antigen from an alternatively spliced third SV40 early mRNA. EMBO J 12: 4739-4746.
29. Voorhoeve PM, Agami R, (2003) The tumor-suppressive functions of the human INK4A locus. Cancer Cell 4: 311-319.
30. Li B, Murphy KL, Laucirica R, Kittrell F, Medina D, et al. (1998) A transgenic mouse model for mammary carcinogenesis. Oncogene 16: 997-1007.
31. Ali-Seyed M, Laycock N, Karanam S, Xiao W, Blair ET, et al. (2006) Cross-platform expression profiling demonstrates that SV40 small tumor antigen activates Notch, Hedgehog, and Wnt signaling in human cells. BMC Cancer 6: 54.
32. Barbanti-Brodano G, Sabbioni S, Martini F, Negrini M, Corallini A, et al. (2004) Simian virus 40 infection in humans and association with human diseases: results and hypotheses. Virology 318: 1-9.
33. Enam S, Del Valle L, Lara C, Gan DD, Ortiz-Hidalgo C, et al. (2002) Association of human polyomavirus JCV with colon cancer: evidence for interaction of viral T-antigen and beta-catenin. Cancer Res 62: 7093-7101.
34. Feng J, Sun Q, Gao C, Dong J, Wei XL, et al. (2007) Gene expression analysis of pancreatic cystic neoplasm in SV40Tag transgenic mice model. World J Gastroenterol 13: 2218-2222.
35. Hoekstra MF, Liskay RM, Ou AC, DeMaggio AJ, Burbee DG, et al. (1991) HRR25, a putative protein kinase from budding yeast: association with repair of damaged DNA. Science 253: 1031-1034.
36. Price MA, (2006) CKI, there's more than one: casein kinase I family members in Wnt and Hedgehog signaling. Genes Dev 20: 399-410.
37. Wang JY, Del Valle L, Peruzzi F, Trojanek J, Giordano A, et al. (2004) Polyomaviruses and cancer-interplay between viral proteins and signal transduction pathways. J Exp Clin Cancer Res 23: 373-383.
38. Ho Y, Mason S, Kobayashi R, Hoekstra M, Andrews B, (1997) Role of the casein kinase I isoform, Hrr25, and the cell cycle-regulatory transcription factor, SBF, in the transcriptional response to DNA damage in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 94: 581-586.
39. Wulf E, Deboben A, Bautz FA, Faulstich H, Wieland T, (1979) Fluorescent phallotoxin, a tool for the visualization of cellular actin. Proc Natl Acad Sci U S A 76: 4498-4502.
40. Giamas G, Hirner H, Shoshiashvili L, Grothey A, Gessert S, et al. (2007) Phosphorylation of CK1delta: identification of Ser370 as the major phosphorylation site targeted by PKA in vitro and in vivo. Biochem J 406: 389-398.
41. Behrend L, Milne DM, Stoter M, Deppert W, Campbell LE, et al. (2000) IC261, a specific inhibitor of the protein kinases casein kinase 1-delta and-epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic effects. Oncogene 19: 5303-5313.
42. Zerrahn J, Utermohlen O, Warnecke G, Deppert W, Lehmann-Grube F, (1996) Protective immunity in BALB/c mice against the simian virus 40-induced mKSA tumor resulting from injection of recombinant large T antigen. Requirement of CD8+ T lymphocytes. J Immunol 156: 3919-3924.
43. Mashhoon N, DeMaggio AJ, Tereshko V, Bergmeier SC, Egli M, et al. (2000) Crystal structure of a conformation-selective casein kinase-1 inhibitor. J Biol Chem 275: 20052-20060.
44. Peifer C, Abadleh M, Bischof J, Hauser D, Schattel V, et al. (2009) 3,4-Diaryl-isoxazoles and-imidazoles as potent dual inhibitors of p38alpha mitogen activated protein kinase and casein kinase 1delta. J Med Chem 52: 7618-7630.
45. Xu RM, Carmel G, Sweet RM, Kuret J, Cheng X, (1995) Crystal structure of casein kinase-1, a phosphate-directed protein kinase. EMBO J 14: 1015-1023.
46. Deppert WR, Normann J, Wagner E, (1992) Adenylate kinase from plant tissues. Influence of ribonuclease on binding properties on Mono Q. J Chromatogr 625: 13-19.
47. Cegielska A, Gietzen KF, Rivers A, Virshup DM, (1998) Autoinhibition of casein kinase I epsilon (CKI epsilon) is relieved by protein phosphatases and limited proteolysis. J Biol Chem 273: 1357-1364.
48. Cegielska A, Virshup DM, (1993) Control of simian virus 40 DNA replication by the HeLa cell nuclear kinase casein kinase I. Mol Cell Biol 13: 1202-1211.
49. Dumaz N, Milne DM, Meek DW, (1999) Protein kinase CK1 is a p53-threonine 18 kinase which requires prior phosphorylation of serine 15. FEBS Lett 463: 312-316.
50. Knippschild U, Milne D, Campbell L, Meek D, (1996) p53 N-terminus-targeted protein kinase activity is stimulated in response to wild type p53 and DNA damage. Oncogene 13: 1387-1393.
51. Pise-Masison CA, Radonovich M, Sakaguchi K, Appella E, Brady JN, (1998) Phosphorylation of p53: a novel pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells. J Virol 72: 6348-6355.
52. Sakaguchi K, Saito S, Higashimoto Y, Roy S, Anderson CW, et al. (2000) Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase. Effect on Mdm2 binding. J Biol Chem 275: 9278-9283.
53. Shieh SY, Ikeda M, Taya Y, Prives C, (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91: 325-334.
54. Vousden KH, (2002) Switching from life to death: the Miz-ing link between Myc and p53. Cancer Cell 2: 351-352.
55. Higashimoto Y, Saito S, Tong XH, Hong A, Sakaguchi K, et al. (2000) Human p53 is phosphorylated on serines 6 and 9 in response to DNA damage-inducing agents. J Biol Chem 275: 23199-23203.
56. Maritzen T, Lohler J, Deppert W, Knippschild U, (2003) Casein kinase I delta (CKIdelta) is involved in lymphocyte physiology. Eur J Cell Biol 82: 369-378.
57. Scheidtmann K, Landsberg G, Graessmann A, (1994) Enhanced kinase-activity in sv40-transformed cells may be compensated by enhanced phosphatase-activity in revertants as reflected by phosphorylation of p53. Int J Oncol 5: 1353-1362.
58. Wolff S, Xiao Z, Wittau M, Sussner N, Stoter M, et al. (2005) Interaction of casein kinase 1 delta (CK1 delta) with the light chain LC2 of microtubule associated protein 1A (MAP1A). Biochim Biophys Acta 1745: 196-206.
59. Longenecker KL, Roach PJ, Hurley TD, (1998) Crystallographic studies of casein kinase I delta toward a structural understanding of auto-inhibition. Acta Crystallogr D Biol Crystallogr 54 (Pt 3): 473-475.
60. Pipas JM, Peden KW, Nathans D, (1983) Mutational analysis of simian virus 40 T antigen: isolation and characterization of mutants with deletions in the T-antigen gene. Mol Cell Biol 3: 203-213.
61. Jannasch K, Dullin C, Heinlein C, Krepulat F, Wegwitz F, et al. (2009) Detection of different tumor growth kinetics in single transgenic mice with oncogene-induced mammary carcinomas by flat-panel volume computed tomography. Int J Cancer 125: 62-70.
62. Boichuk S, Hu L, Hein J, Gjoerup OV, (2010) Multiple DNA damage signaling and repair pathways deregulated by simian virus 40 large T antigen. J Virol 84: 8007-8020.
63. McKnight RA, Shamay A, Sankaran L, Wall RJ, Hennighausen L, (1992) Matrix-attachment regions can impart position-independent regulation of a tissue-specific gene in transgenic mice. Proc Natl Acad Sci U S A 89: 6943-6947.
64. Robinson GW, McKnight RA, Smith GH, Hennighausen L, (1995) Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. Development 121: 2079-2090.
65. Sandgren EP, Schroeder JA, Qui TH, Palmiter RD, Brinster RL, et al. (1995) Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice. Cancer Res 55: 3915-3927.
66. Gan DD, Khalili K, (2004) Interaction between JCV large T-antigen and beta-catenin. Oncogene 23: 483-490.
67. Sablina AA, Hector M, Colpaert N, Hahn WC, (2010) Identification of PP2A complexes and pathways involved in cell transformation. Cancer Res 70: 10474-10484.
68. Brennan KR, Brown AM, (2004) Wnt proteins in mammary development and cancer. J Mammary Gland Biol Neoplasia 9: 119-131.
69. Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, et al. (2000) Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci U S A 97: 4262-4266.
70. Schlosshauer PW, Brown SA, Eisinger K, Yan Q, Guglielminetti ER, et al. (2000) APC truncation and increased beta-catenin levels in a human breast cancer cell line. Carcinogenesis 21: 1453-1456.
71. Schlosshauer PW, Pirog EC, Levine RL, Ellenson LH, (2000) Mutational analysis of the CTNNB1 and APC genes in uterine endometrioid carcinoma. Mod Pathol 13: 1066-1071.
72. Farago M, Dominguez I, Landesman-Bollag E, Xu X, Rosner A, et al. (2005) Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis. Cancer Res 65: 5792-5801.
73. Mani M, Carrasco DE, Zhang Y, Takada K, Gatt ME, et al. (2009) BCL9 promotes tumor progression by conferring enhanced proliferative, metastatic, and angiogenic properties to cancer cells. Cancer Res 69: 7577-7586.
74. Rampias T, Boutati E, Pectasides E, Sasaki C, Kountourakis P, et al. (2010) Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells. Mol Cancer Res 8: 433-443.
75. Vleugel MM, Greijer AE, Bos R, van der Wall E, van Diest PJ, (2006) c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer. Hum Pathol 37: 668-674.
76. Yang W, Yan HX, Chen L, Liu Q, He YQ, et al. (2008) Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Cancer Res 68: 4287-4295.
77. Jiao X, Katiyar S, Willmarth NE, Liu M, Ma X, et al. (2010) c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion. J Biol Chem 285: 8218-8226.
78. Heinlein C, Krepulat F, Lohler J, Speidel D, Deppert W, et al. (2008) Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis. Int J Cancer 122: 1701-1709.
79. Hermannstadter A, Ziegler C, Kuhl M, Deppert W, Tolstonog GV, (2009) Wild-type p53 enhances efficiency of simian virus 40 large-T-antigen-induced cellular transformation. J Virol 83: 10106-10118.
80. Li R, Sonik A, Stindl R, Rasnick D, Duesberg P, (2000) Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy. Proc Natl Acad Sci U S A 97: 3236-3241.
81. Li R, Yerganian G, Duesberg P, Kraemer A, Willer A, et al. (1997) Aneuploidy correlated 100% with chemical transformation of Chinese hamster cells. Proc Natl Acad Sci U S A 94: 14506-14511.
82. Gurney EG, Tamowski S, Deppert W, (1986) Antigenic binding sites of monoclonal antibodies specific for simian virus 40 large T antigen. J Virol 57: 1168-1172.